Nexamar miss/ hit trials lung cancerhttps://www.reuters.com/article/rbssHealthcareNews/idUSLF3018820090515
Everyone is getting into lung cancer. Competition is heating between the giants pharmas.
All their drugs sucks, not much improvement than with chemeo...
Expensive. Side effects...
They all need TLN-4601 to increase efficacy and win the cancer war...
Another hit miss trial for Nexamar...